BNP Paribas Financial Markets Buys 37,575 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

BNP Paribas Financial Markets boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 20.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 222,057 shares of the company’s stock after acquiring an additional 37,575 shares during the quarter. BNP Paribas Financial Markets owned 0.18% of Henry Schein worth $15,366,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Palestra Capital Management LLC acquired a new stake in shares of Henry Schein during the 4th quarter worth about $182,988,000. Lyrical Asset Management LP bought a new position in shares of Henry Schein in the fourth quarter valued at approximately $126,655,000. Norges Bank acquired a new position in shares of Henry Schein in the 4th quarter worth approximately $103,301,000. National Bank of Canada FI grew its position in Henry Schein by 102.4% during the 4th quarter. National Bank of Canada FI now owns 1,084,511 shares of the company’s stock worth $75,048,000 after acquiring an additional 548,561 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Henry Schein during the 4th quarter valued at $34,720,000. 96.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on HSIC shares. UBS Group decreased their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Jefferies Financial Group raised their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Piper Sandler reduced their target price on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 30th. Barrington Research lowered their price target on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a report on Tuesday, May 6th. Finally, Wells Fargo & Company reduced their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein has an average rating of “Moderate Buy” and a consensus price target of $79.30.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.08% of the company’s stock.

Henry Schein Stock Performance

HSIC stock opened at $68.68 on Friday. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.41 billion, a P/E ratio of 28.26, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The business’s fifty day moving average is $67.59 and its 200-day moving average is $71.45.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The firm had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue was down .1% compared to the same quarter last year. During the same quarter last year, the business earned $1.10 earnings per share. Equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.